Published in Lab Business Week, February 5th, 2006
Study 1: Tumor necrosis factor-alpha (TNF-alpha) impacts survival in patients with myelodysplastic syndromes (MDS).
"An excessive intramedullar progenitor cell apoptosis, to which elevated expression of TNF-alpha might contribute, is considered the main cause of inefficient hematopoiesis in MDS. Enhanced bone marrow (BM) angiogenesis is regarded as an essential cofactor in the progression of MDS to acute myelogenous leukemia (AML) and microvessel formation may be induced by TNF-alpha as well," scientists in Austria report.
"To investigate TNF-alpha...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.